semaglutide health canada 1st generic version of Ozempic approved by Health Canada approves 2nd generic

Other important safety considerations include: Pancreatitis : Patients should be informed about symptoms (severe, persistent abdominal pain, sometimes radiating to the back, with or without vomiting) and seek urgent medical attention if these occur Gallbladder disease : Semaglutide may increase the risk of gallstones Dehydration and acute kidney injury : Particularly if GI side effects are severe Pregnancy and breastfeeding : Wegovy is contraindicated during pregnancy and should be discontinued at least 2 months before a planned pregnancy

If you are a good candidate and choose to do the program, your prescription will be sent to the compounding pharmacy after your appointment

The FDA maintains a drug shortage database based on several key criteria: When manufacturers report anticipated disruptions or discontinuances in drug production When the FDA becomes aware of significant supply issues through market surveillance When healthcare providers or patients report consistent difficulty obtaining medications When a drug's demand significantly exceeds available supply On October 30, 2024, Novo Nordisk confirmed that all doses of Wegovy and Ozempic are now listed as available in the U.S., although the company cautioned people may still experience variability in filling their prescriptions

Glucose Intolerance Tesamorelin treatment may result in glucose intolerance